News Hub | News Direct

Advanced AI Drug Development Platform 'DeepMatcher®' 2.0 Launches Worldwide (226330.KQ)

Syntekabio, Inc.

SyntekaBio (226330.KQ)(226330:KS), an AI drug discovery and development company, announced the successful completion of its DeepMatcher® 2.0 performance verification. The advanced version of an AI small molecule drug discovery technology is ready to launch in the global market. The company opened its regional U.S. office in New York City in August. SyntekaBio has developed and verified DeepMatcher® into a three-step process: 1D/2D/3D virtual pre-screening (DMC-PRE), screening by best binding pose and binding energy prediction (DMC-SCR), and molecular dynamics-based self-verification (DMC-MD), which has utilized 1 billion compounds and 600 target models. In silico validation performed on these three modules has authenticated 85-95 percent accuracy, a competitive level in sensitivity and specificity. DeepMatcher® ’s performance is greatly enhanced by the DMC-MD process, in which the molecular dynamic simulation process in the final stage proves to significantly reduce the false positive results that commonly occur and lead to misinterpretation when predicting new drug candidates. The molecular dynamics simulation process typically requires vast computational resources to generate highly accurate results in the screening process. SyntekaBio’s own supercomputing infrastructure is capable of fully supporting the simulation, a major advantage over its competitors. Thus far, the outcome of the screening process evidently points towards the future where it can be applied to the discovery of ‘Molecular Glue’ that can promote and stabilize PPI (Protein-Protein Interaction) between ubiquitin ligase and its target protein. SyntekaBio has also completed the validation of a large-scale drug repurposing project that has been ongoing since the third quarter of 2021. This project was conducted using DeepMatcher® to derive a previously unknown drug-target combination by predicting the binding force between approximately 3,000 drugs and 400 target proteins. By validating approximately 6,000 combinations from the project with in vitro binding efficacy tests, SyntekaBio was able to secure a new effective drug group from a total of 120 protein groups, including the Kinase family, GPRC, Methyltransferase, Deacetylase and Phosphodiesterase. Therefore, the efficacy of DeepMatcher® is positively verified, providing the basis for pipeline development for various disease groups. “We are thrilled to confirm encouraging results from a long-awaited outcome of DeepMatcher® version 2.0 experimentation. SyntekaBio is preparing to launch our AI drug cloud PaaS (Platform as a Service) system based on DeepMatcher® 2.0. We look forward to sharing our cutting-edge technology to enhance drug discovery and development capabilities in the U.S. and internationally,” said SyntekaBio CEO Jongsun Jung, Ph.D. The drug group discovered through SyntekaBio’s large-scale drug repurposing project is undergoing cell experiments in various fields such as anti-cancer, anti-inflammatory, hair loss prevention and growth, and central nervous system diseases. For business development meetings and information about SyntekaBio’s products and services, contact the New York office at +1 (212) 371-2544 or admin.usa@syntekabio.com. Syntekabio is a global artificial intelligence (AI) and big data-based drug discovery and development company, headquartered in South Korea since 2009, with its U.S. operations bringing innovative technologies and science to create transformative medicines worldwide that are compliant with international standards to cure diseases and improve people's lives. Find out more about DeepMatcher®, NEO-ARS™, NGS-ARS™ and PGM-ARS™ at www.syntekabio.com. Contact Details SyntekaBio USA | WMSG Sabina Lee +1 201-402-1400 wgroup@wmedical.org

September 21, 2022 10:07 AM Eastern Daylight Time

Aqua Cultured Foods Unveils Alt-Seafood Dumpling Fillings for Asian Food Go-to-Market Partners

AquaCultured Foods

Food tech startup Aqua Cultured Foods today announced it has developed a minced dumpling filling for its future go-to-market partners specializing in Asian foods including retail and foodservice distributors. One filling option uses Aqua’s alternative shrimp in a bulk, unseasoned format for partners to customize their preparations, which then can be packaged and co-branded. Whether they’re called mandu, jiaozi, or gyoza, dumplings are a dietary staple in countries like South Korea, China and Japan—as beloved as burgers are to North Americans. The global market for frozen dumplings was $5.825 billion U.S. in 2020, and is expected to rise to more than $10 billion by the end of 2027. Traditionally dumplings may be filled with meats, seafood, tofu, and/or vegetables. While Aqua’s R&D focus has been on whole-muscle cut, sushi-quality filets with the same visual appeal of high-grade fish, dumplings can use off-cuts, trims and less than visually perfect filets for minced fillings. Achieving the proper size and texture for filling can also be done economically at scale in large batches, and requires less fermentation time. “We’re glad our partners challenged us to work on dumplings, and lucky to have their guidance through the process of perfecting the taste and filling for Asian palates,” said Aqua chief growth officer Brittany Chibe. “I’m especially happy that this product moves us closer to zero-waste by finding use for our off-cuts, with the added bonus that it’s very efficient to make in volumes appropriate for foodservice.” Interest around Aqua’s minced fillings is not limited to dumplings, nor to shrimp. Other alt-seafood varieties are likely to follow for applications including spicy tuna sushi rolls, seafood cakes/patties, ravioli and cannelloni, and others. Aqua is developing mycoprotein-based calamari, shrimp, scallops, and filets of animal-free tuna and whitefish with a realistic taste and texture. Aqua’s fermentation methods do not use any animal inputs, genetic altering or modification, and can be marketed as non-GMO. Unlike plant-based processed foods formulated with starches and protein isolates, Aqua’s alt-seafood retains its naturally occurring fiber, protein, and other micronutrients. Aqua has recently showcased its alt-seafood for current and prospective partners representing Europe, Asia, and North America. Public tasting events will gauge consumer acceptance later this year with select restaurant partners, followed by in-market product introductions via strategic partners in 2023. ‎About Aqua Cultured Foods Aqua Cultured Foods is an innovative food technology startup developing the world’s first whole-muscle cut seafood alternatives created through microbial fermentation. Its novel technology produces a sustainable, complete protein source using only a fraction of the resources required by traditional aquaculture. As an R&D company with a focus on product commercialization, Aqua Cultured Foods occupies a unique position in the burgeoning alt-seafood market as well as within the fermentation industry. The company’s mission is to mitigate global challenges such as overfishing, climate change and feeding the world’s expanding population with delicious, nutrient-rich foods. Investors include Supply Change Capital, Aera VC, HPA, Sustainable Food Ventures, Hanfield Venture Partners, Lifely VC, Conscience VC, Kingfisher Capital, Big Idea Ventures, and Gonzalo Ramirez Martiarena. For more information visit https://www.aquaculturedfoods.com. Contact Details Evolotus PR Gary Smith +1 818-783-0569 gary@evolotuspr.com Company Website https://www.aquaculturedfoods.com

September 21, 2022 08:38 AM Eastern Daylight Time

Image

Under The Hood Of Options Chain Implications — Understanding How Options Data Can Help Inform Investment Decisions

Protalix BioTherapeautics Inc.

As many investors are aware, options market data can provide some critical insight into future price movements of underlying common stock. It’s often possible to tell how the broader market perceives a company by looking at how options traders are trading it. As a refresher: A "call" or call option is a right to buy an asset at a predetermined price. If traders are buying more puts than calls, it indicates that they expect the price of the underlying security to go down. If they are buying more calls than puts, it suggests that they see a bull market ahead for the security. But options data alone is typically not enough, and it’s always important to conduct one’s own fundamental analysis; for instance, in the pharmaceuticals industry, one could look at factors like upcoming biologics license applications (BLA) - these are usually submitted by companies developing vaccines and other allergenic drug products, blood products, and cellular and genetic therapies. As an example, recent options data points could be helpful in understanding how traders feel about what the future may hold for Protalix BioTherapeutics Inc. (NYSE: PLX). This Israel-based pharmaceutical company focuses on developing, producing, and commercializing recombinant therapeutic proteins produced through its proprietary ProCellEx ® plant cell-based protein expression system. Momentum Toward Finding A Cure For Fabry? Protalix received good news recently from its trial evaluation of the safety and efficacy of its Fabry disease drug compared to benchmark drug agalsidase beta (as part of what is referred to as the BALANCE trial). The study supported Protalix’s efforts to combat Fabry disease, which affects the heart, kidneys, brain, central nervous system, and skin. It is an inherited condition passed from parent to child and is sometimes called Anderson-Fabry disease. Companies currently working on developing gene therapies for Fabry disease include Avrobio Inc. (NASDAQ: AVRO), Freeline Therapeutics Holdings PLC (NASDAQ: FRLN), and Sangamo Therapeutics Inc. (NASDAQ: SGMO). Protalix Positive About Its Q2 Performance Encouraged by the results of their trial, Protalix and its partner Chiesi Global Rare Diseases have announced new topline data from the study. Because the BALANCE trial met its primary endpoint and the drug showed favorable tolerability and immunogenicity profile, Protalix says it will be included in its planned BLA application to the Food and Drug Administration (FDA) by the end of 2022. A BLA is a request to distribute a biologic across states. It is usually submitted after an investigational new drug or an investigational device exemption and after the appropriate studies have been conducted. A biologics license application generally applies to vaccines, allergenic drug products, blood products, and cellular and genetic therapies. Resubmissions of BLA applications are made to answer any company deficiencies that need to be addressed by the applicant before approval. The recent study results are one of the positive momentum examples pointed out by Protalix at the end of the second quarter of 2022, including a 36% increase in revenue to $8.8 million over results from the second quarter of 2021 and license revenue and research and development services up 69% to $5.4 million. A look at the options market data for Protalix could help investors understand how the broader market sees these factors impacting the company’s stock. Traders who are unfamiliar with the complexity of options may want to take the dive into learning more to help round out indicators, especially for individual tickers like PLX — and even traders that are already used to observing the options chain, bid/ask spread, implied volatility, and more may want to take a deeper look at the implications of what the market is saying, such as expectations on clinical trials, financial results, and what the future may look like. For more information on Protalix BioTherapeutics, visit www.protalix.com. Protalix is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx. Protalix was the first company to gain U.S. Food and Drug Administration (FDA) approval of a protein produced through plant cell-based in suspension expression system. Protalix's unique expression system represents a new method for developing recombinant proteins in an industrial-scale manner.Protalix's first product manufactured by ProCellEx, taliglucerase alfa, was approved by the FDA in May 2012 and, subsequently, by the regulatory authorities of other countries. Protalix has licensed to Pfizer Inc. the worldwide development and commercialization rights for taliglucerase alfa, excluding Brazil, where Protalix retains full rights.Protalix's development pipeline consists of proprietary versions of recombinant therapeutic proteins that target established pharmaceutical markets, including the following product candidates: pegunigalsidase alfa, a modified stabilized version of the recombinant human α–Galactosidase–A protein for the treatment of Fabry disease; alidornase alfa or PRX–110, for the treatment of various human respiratory diseases or conditions; PRX–115, a plant cell-expressed recombinant PEGylated uricase for the treatment of severe gout; PRX–119, a plant cell-expressed long action DNase I for the treatment of NETs-related diseases; and others. Protalix has partnered with Chiesi Farmaceutici S.p.A., both in the United States and outside the United States, for the development and commercialization of pegunigalsidase alfa. This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Chuck Padala, Managing Director- LifeSci Advisors +1 646-627-8390 chuck@lifesciadvisors.com Company Website https://protalix.com/

September 21, 2022 08:00 AM Eastern Daylight Time

California Passes Landmark Clean Lighting Bill

Clean Lighting Coalition

On Sunday, California Governor Gavin Newsom signed AB 2208 into law, a landmark bill by Assemblymember Kalra and Senator Becker that sets phase out dates for compact fluorescent lamps (CFLs) and linear fluorescent lamps (LFLs) starting in 2024. Climate, clean air, worker safety, and public and environmental health advocates applaud the move to protect Californians and the planet from the dangers of mercury containing lamps. “We are delighted to have legislative champions in Assemblymember Ash Kalra and Senator Josh Becker who were willing to take action to remove toxic mercury from lighting which unnecessarily exposes the public and waste workers to a potent neurotoxin,” said Heidi Sanborn, Executive Director of bill sponsor, the National Stewardship Action Council (NSAC). Over the past 10 years, light emitting diodes (LEDs) have become an increasingly available, cost-effective, and much more efficient lighting alternative. Because LEDs use half as much electricity as fluorescents, the bill will double lighting cost savings for Californians and protect the state from rolling blackouts caused by energy shortages. Victoria Rome, Director of California Government Affairs for Natural Resource Defense Council (NRDC) shared, “In the past, despite their mercury content, fluorescent lamps were tolerated – and even promoted – because they were the most energy-efficient option at the time. But that is no longer the case. AB 2208 is an important climate protection measure that will result in significant electricity and carbon dioxide emissions savings.” A recent market study found that by 2030, California could save over $1 billion annually on electricity bills, achieve annual electricity savings of about 5,600 gigawatt hours, and avoid the release of 950,000 metric tons of CO 2 per year. California is now the second state to pass a ban on fluorescent lamps, following Vermont’s vote to phase out CFLs in 2023 and 4-foot LFLs in 2024. California, however, went further by including lamps up to 8 feet in the phase-out. “We are excited to see California pull ahead as a global leader in clean lighting,” said Corinne Schneider of the Clean Lighting Coalition. "We hope California’s move will generate some momentum, with other states taking action to protect people and the planet from fluorescent lighting.” Governments around the world are increasingly recognizing LEDs as the foremost lighting technology on the market today. On December 16, the European Union banned the sale of almost all mercury-containing fluorescent lamps by September 2023, and in March, 137 governments voted to phase out CFLs by 2025 through the Minamata Convention on Mercury. As one of the biggest lighting markets in the country, the California ban signals that the US is ready to make the transition to a clean lighting economy. The US is well positioned to take a leading role in global negotiations and push for an equitable global transition to better lighting at the Minamata Convention COP5 next year. About the Clean Lighting Coalition The Clean Lighting Coalition is a global partnership coordinated by CLASP to capture the health and environmental benefits of eliminating mercury-based lighting. To learn more, visit www.cleanlightingcoalition.org and follow the Coalition on Twitter and LinkedIn. About the National Stewardship Action Council The National Stewardship Action Council was founded in 2015 as a 501(c)(4) nonprofit organization that engages in education and advocacy work that drives a circular and equitable economy, anywhere in the U.S., and at any level of government. Our vision is that the U.S. achieve a circular and equitable economy. You can follow us on social media via Facebook, Twitter, LinkedIn, and YouTube. Contact Details Alexia Ross +1 339-222-4311 aross@clasp.ngo Company Website https://www.cleanlightingcoalition.org

September 20, 2022 07:00 AM Pacific Daylight Time

Understanding Hearing Loss: Don’t Miss Out on Hearing the Moments that Matter Most

YourUpdateTV

Untreated hearing loss not only disconnects you from family, friends, and work, it exposes you to higher risk of dementia, depression, memory loss, injury, and cognitive decline. Recently, licensed audiologist, Dr. Cliff Olson, conducted a satellite media tour to talk about hearing loss and the importance of addressing it from a trusted healthcare professional. A video accompanying this announcement is available at: https://youtu.be/xgXK9jvhssc Hearing loss is a major health issue, around the world and in the U.S. The National Institute on Deafness and Other Communication Disorders estimates that 1 in 8 Americans aged 12 or older — about 30 million people — has lost some hearing in both ears. While men are almost twice as likely as women to having hearing loss, it is an issue that is often unaddressed or undertreated by many. In fact, according to the National Institutes of Health, ~ 37.5 million adults report some trouble hearing and an estimated 28.8 million U.S. adults with mild to severe hearing loss could benefit from hearing aids. Too often, people delay seeking care. There are several reasons individuals may delay addressing hearing loss, including: Recognizing and accepting that one may have hearing loss Typical symptoms of hearing loss include having trouble hearing people on the phone, turning up the TV volume, becoming tired from listening and hearing and being able to understand conversations when there’s background noise. Access to HCPs, and misperceptions associated with hearing aids. Hearing aids have evolved so much, so the good news is that: Hearing aids are totally different now with new and improved tech features. Users are getting younger…with average purchase age dropping from 68 to 60. The time people are waiting to purchase hearing aids has dropped to 4 years…not the 6 or 7 years it used to take. Users rarely or never feel embarrassed they wear hearing aids. That’s because they look so cool and do so many great things to connect you to your world. In fact, user satisfaction with hearing aids has increased significantly in the past 20+ years…from 58% to 83%. Hearing speech in noisy environments is still a challenge for people with hearing loss. In fact, 80% of people who wear hearing aids describe hearing in noise as a key challenge. (MarketTrak 2019) The newest hearing aid from GN, ReSound OMNIA, addresses the No.1 hearing aid challenge – hearing speech in noise. ReSound OMNIA allows people to hear and connect with the world naturally, thanks to an outstanding 150% improvement in speech understanding. Go to ReSound.com for a free hearing screening and additional resources for understanding hearing loss and helping family members who are also struggling with hearing loss. About Dr. Cliff Olson Dr. Cliff Olson, from Phoenix, Arizona, USA, is a Doctor of Audiology, advocate for better hearing and creator of popular YouTube channel, Dr Cliff Aud - Doctor Cliff, AuD - YouTube - where he posts educational information about hearing care and hearing aids. The channel has 220k subscribers and has received over 34 million views. Dr. Olson is also the founder of Hearing Up – www.hearingup.com - a network where people can get connected to local experienced hearing professionals who are committed to best practices. A Board-Certified Audiologist, Dr. Olson holds his doctoral degree from the University of Illinois where he is a lecturer for the Department of Speech & Hearing. He is a member of the Academy of Doctors for Audiology and a Fellow of the American Academy of Audiology. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

September 19, 2022 11:33 AM Eastern Daylight Time

Video

NanoViricides Reports Its Novel Monkeypox Antiviral Could Reach Clinical Status Rapidly

NanoViricides, Inc.

Learn More about NanoViricides, Inc. by gaining access to the latest research report As cases of the monkeypox virus continue to grow, the race is on for a way to fight this once-rare disease. Since the first reports of monkeypox infection in the United States started popping up in May, cases have now been reported in all 50 states for a total of over 23,000 new infections. In response to that rapid spread, NanoViricides Inc. (NYSEAMERICAN: NNVC) wants to speed up the timeline on the development of its novel antiviral platform to treat the monkeypox virus. Here’s the company’s plan for bringing its monkeypox drug development platform to clinical trials sooner. NanoViricides’s Rapid Drug Development Program For Monkeypox Antiviral Having already begun drug development of NV-387-T, its monkeypox drug candidate, NanoViricides reports that it’s optimistic it can speed up the process to move the antiviral into human clinical trials quickly. Its reasons for that optimism are twofold. First, the active ingredient tecovirimat has already been approved by the Food and Drug Administration (FDA) as a smallpox treatment. Thanks to the FDA’s recent expanded-access protocol, it’s also already being administered to monkeypox patients in the form of TPOXX, an antiviral infusion manufactured by Catalent Inc. (NYSE: CTLT) and distributed by SIGA Technologies Inc. (NASDAQ: SIGA). Second, NanoViricides is optimistic that it can use preclinical data from its other drug development programs to support its application for NV-387-T. That’s because the novel component in its monkeypox drug candidate is NV-387, the same as that used in NV-CoV-2, the company’s COVID-19 drug candidate. NV-387-T encapsulates the already FDA-approved Tecovirimat (for smallpox) within the belly of the NV-387 polymeric micelles, providing substantial additional benefits. That COVID-19 antiviral (NV-387) has already gone through preclinical development and NanoViricides is already working to initiate clinical trials of the drug candidate, so all of that data could be used to meet the safety and toxicology requirements for an investigational new drug (IND) application of NV-387-T for monkeypox with the FDA. NanoViricides’s NV-387-T Could Offer More Effective, More Practical Monkeypox Treatment The current TPOXX treatment has helped doctors combat the recent monkeypox outbreak, but it also comes with some drawbacks. The formulation is an infusion that takes six hours per dose, making it a time-consuming treatment that must be administered at a hospital. It’s also not safe for patients with severe renal impairment (kidney damage). The NV-387-T drug candidate NanoViricides is developing, on the other hand, it would be a 30-minute injection, and the company is also working on an oral version that would eliminate the need for a hospital visit. TPOXX is available as oral capsules which are used in most cases except for severe hospitalized cases at present. NanoViricides believes NV-387-T oral formulation may have substantial advantages in improving the pharmacokinetics and effectiveness of tecovirimat compared to the current TPOXX oral capsules. By encapsulating the active ingredient (tecovirimat) in NanoViricides’s NV-387 platform, the company hopes to make tecovirimat both more effective and safe for patients with kidney damage. In preclinical studies of the company’s COVID-19 drug candidate, NV-387 encapsulation of remdesivir showed improved pharmacokinetics (how well a drug moves through the body) and pharmacodynamics (how the body responds to the drug) compared to Gilead Sciences Inc. ’s (NASDAQ: GILD) formulation. NanoViricides believes that’s because encapsulation prevents the body from metabolizing the drug so it’s able to remain in the system at higher concentrations for longer periods of time. It’s that improved ability to remain in the body that would potentially decrease the risk of kidney toxicity resulting from rapid metabolizing of the drug. And the stability of NV-387 encapsulation compared to the current TPOXX injectable formulation is expected to help reduce infusion time from six hours to 30 minutes. As the company works to speed up development and move its novel Monkeypox antiviral into human clinical trials quickly, it hopes to be able to offer a safer, more effective treatment to combat this outbreak as soon as possible. About NanoViricides NanoViricides, Inc. (the "Company") (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for antiviral therapy. The Company's novel nanoviricide® class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. Our lead drug candidate is NV-HHV-101 with its first indication as dermal topical cream for the treatment of shingles rash. In addition, we are developing a clinical candidate for the treatment of COVID-19 disease caused by SARS-CoV-2 coronavirus. The Company cannot project an exact date for filing an IND for this drug because of its dependence on a number of external collaborators and consultants.The Company is now working on tasks for completing an IND application. The Company is currently pursuing two separate drug candidates for the treatment of COVID-19 patients. NV-CoV-2 is our nanoviricide drug candidate that does not encapsulate Remdesivir. NV-CoV-2-R is our other drug candidate that is made up of NV-CoV-2 with Remdesivir encapsulated in it. The Company believes that since Remdesivir is already US FDA approved, our drug candidate encapsulating Remdesivir is likely to be an approvable drug, if safety is comparable. Remdesivir is developed by Gilead. The Company has developed both of its own drug candidates NV-CoV-2 and NV-CoV-2-R independently.The Company intends to re-engage into an IND application to the US FDA for NV-HHV-101 drug candidate for the treatment of shingles once its COVID-19 project moves into clinical trials, based on resources availability. The NV-HHV-101 program was slowed down because of the effects of recent COVID-19 restrictions, and re-prioritization for COVID-19 drug development work.The Company is also developing drugs against a number of viral diseases including oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others. NanoViricides' platform technology and programs are based on the TheraCour® nanomedicine technology of TheraCour, which TheraCour licenses from AllExcel. NanoViricides holds a worldwide exclusive perpetual license to this technology for several drugs with specific targeting mechanisms in perpetuity for the treatment of the following human viral diseases: Human Immunodeficiency Virus (HIV/AIDS), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Rabies, Herpes Simplex Virus (HSV-1 and HSV-2), Varicella-Zoster Virus (VZV), Influenza and Asian Bird Flu Virus, Dengue viruses, Japanese Encephalitis virus, West Nile Virus, Ebola/Marburg viruses, and certain Coronaviruses. The Company intends to obtain a license for poxviruses if the initial research is successful. The Company's technology is based on broad, exclusive, sub-licensable, field licenses to drugs developed in these areas from TheraCour Pharma, Inc. The Company's business model is based on licensing technology from TheraCour Pharma Inc. for specific application verticals of specific viruses, as established at its foundation in 2005. This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Contact Details NanoViricides, Inc. +1 203-937-6137 info@nanoviricides.com Company Website http://www.nanoviricides.com

September 19, 2022 09:26 AM Eastern Daylight Time

News Release

7 Best Personal Statement Writing Services for Colleges and Grad Schools

Writing Solutions

When you are in college, you have to write a lot of papers and essays. And it doesn't get any better when you graduate. You must submit applications for internships, scholarships, and jobs — all of which require writing an essay in some form. And even if there isn't a formal writing requirement, many people prefer to send their resume with a cover letter rather than just sending their resume by itself. Everyone knows that what matters in your college admission process is your GPA and SAT/ACT scores. But it's not the only thing that matters - your personal statement matters so much! It's important for you to stand out from other students and show why you're the top candidate for that university. That's where a good personal statement help will get you the results you want. This is an important tool that students, particularly at the high school level, need in order to be admitted to a university or college of their choice. The entire process of writing one needs help, especially if you haven't had experience before or if English is your first language. But what if you are not a good writer, or don’t have any idea how to write a personal statement? There are TOP 7 professional writing services that can help you craft one that will impress the administration and boost your chance of getting into your chosen school. 99Papers - #1 personal statement service for colleges PaperHelp - The best personal statement service in the USA EssayFactory - UK-based company for law school papers EssayBox - Highest Quality Paper Writing for grad school Ivory Research - Professional UK writers Studdit - Medical school personal statement writing company Expert-Editing - The best statement editing provider Here are reviews of the best personal statement writing/editing services to help you get started on your path to the college or grad school you choose. #1. 99Papers 99Papers is a personal statement writing service that helps students write outstanding college application essays. With their high-quality writers, you will be able to write an essay that will help you get into the school of your dreams or improve your grade average. They offer additional services, such as resume writing, proofreading and editing, personal statement editing, recommendation letter writing, and much more. All of their efforts are geared toward helping you succeed. Since 2008, they have helped many students improve their writing with quality academic assistance. They are a team of professional writers with years of experience helping students like you write their college application papers. Because they've been in the business for so long, they know exactly what colleges are looking for in an essay and how to tailor your writing style to match their expectations. Your essay will stand out from the rest by working with a professional writer and you'll be accepted to your dream college! Their process is very easy and streamlined for efficiency. You can speak with a 99Papers customer service agent by phone or chat to discuss your needs and how they can help you. Your information is never shared with any outside parties, so you can rest assured your personal data is safe. Pricing varies by task and the number of pages ordered. You will be paired with a writer who is knowledgeable about the topic of your paper and knows what needs to be included for you to get passing scores. Advantages: Top-quality writing; 100% error-free; Unlimited revisions; Reputable company - rated 9.9; Great customer service; Professional services; Affordable pricing starts at $9.95 per page; Discounts for repeat orders. Disadvantages: A plagiarism report is available, but for an additional cost. #2. PaperHelp PaperHelp is a professional personal statement and SOP writing service with over 10 years of experience helping students to succeed in their studies. They take pride in the fact that they help more than 20,000 students every year. Some of the students who came to them for assistance were able to get into some of the most prestigious universities in the world, including Harvard, Oxford, and Cambridge. Its mission is to work with clients to ensure they get the best writing services at affordable prices. The writers are experts in their fields and their know exactly how to help you succeed academically. No matter what your academic goal is, PaperHelp can help you reach it! The process is easy. Just fill out their order form and then upload your materials or give them an outline for your paper topic. They will provide a free quote for your project so that you know exactly what their writers charge for their work before placing an order. Once you place an order, they will assign one of their professional writers to your project and they will begin working on it immediately after receiving all of your requirements. You are able to communicate with them via email at any time during this process if needed. Prices vary by the level of writer skill & experience (intermediate or industry expert) and the number of pages needed. The type of content will also determine the level of skill necessary to accomplish your task. Advantages: High-quality content; Affordable pricing; Editing/proofreading; 100% error-free; Budget-friendly at $9.95 per page; Discounts are promo codes. Disadvantages: Plagiarism reports are included for an additional fee; Source materials are available, for an additional fee. #3. EssayFactory EssayFactory is your one-stop shop for all of your academic writing needs. Their company provides professional writers from UK to compose your essays, term papers, personal statements, SOP, research papers, and more. With hundreds of writers in their network, you can be sure to find a writer that meets your needs. They have been around since 2002 and have worked with thousands of students from all over the world. Their clients come from all walks of life and from various countries, such as Australia, Canada, United States, United Kingdom, Malaysia, Singapore, Indonesia, and many others. Working in this industry for so many years, they understand how stressful it is when you have an important essay or term paper coming up while still having to juggle other commitments like projects and assignments. EssayFactory is staffed by professional writers who have earned degrees from some of the most prestigious universities in the world. They know exactly how to put together a winning application package that will impress admissions officers. Their website is easy to navigate, so you can find answers to your questions immediately. They also have customer support via chat available 24/7 for questions or last-minute orders. If you need resume writing help or editing for a different project, they can help you with that too. You are always in control of your project. They offer unlimited revisions if you are unhappy with any part of your delivery. They have a good reputation for delivering quality material, which is probably due to the fact that they employ expert writers and offer revisions at no extra cost. Advantages: Unlimited edits/revisions; 24/7 customer support; Professional UK writers; Slightly higher pricing for services (starts at $11 per page); 100% error-free; Discounts available. Disadvantages: Lacks some of the personalized aspects of previous services #4. EssayBox EssayBox is another professional writing company that offers personal statement writing help for students of all academic levels. They offer professional writers and editors to help you with all your academic assignments. Top-notch writers are ready to take on any assignment, whether it's a research paper, an essay, or even a dissertation. Due to their experience working with students, they know how important it is to meet deadlines. Therefore, they offer 24/7 services year-round! Whatever subject you're studying or whatever assignment you need help with, they will do their best to assist you. The company has been operating since 2005 and they have helped thousands of students achieve their goals by providing them with high-quality, custom-written papers and other types of academic content. Their team consists of experienced writers who know how to meet even the most challenging requirements in their field of study. Quality and plagiarism checks are done using anti-plagiarism software before delivery to the client. They are competitively priced to be affordable so that every student can afford them - especially those who are struggling financially because they are not sure whether they will be able to complete their coursework on time or not. The goal of their service is to make sure your application stands out and gets you accepted into the college or university of your choice. EssayBox is staffed by a team of professional writers who will help you craft a perfect personal statement that will grab the attention of admissions officers at the schools of your choice. Advantages: Expert writers & editors; Professional writing; Error-free; Plagiarism-free; Knowledgeable on any topic; Unlimited revisions. Disadvantages: Pricing is higher at $12 per page, but you do get free ad-ons. #5. Ivory Research Ivory Research is a company similar to the ones above that offers professional writing for students applying to colleges, graduate programs, and high schools in the United Kingdom. They work with clients from all over the world on projects ranging from personal statements to supplemental essays to admission tests like the SAT or GRE. They also offer editing services for papers written by students in high grad school or college as well as professionals in various fields such as medicine or law. Ivory Research offers editing services as well as editing proofreading services for those who wish to improve their existing work or just want a second opinion on their paper before submitting it. What’s unique about this service is that they don’t just cater to students, they provide a whole list of services for people outside of the academic world as well. If you’ve been given the task of writing a business plan for an upcoming meeting but are struggling with writer’s block, this will definitely give you the break you need to refocus your thoughts and efforts. Advantages: Many years of experience (in business since 2005); Quality and plagiarism checks prior to delivery; 24/7 live support via chat & email; Many of their writers hold bachelor’s or master’s degrees. Disadvantages: Pricing is not stated clearly on the website, you have to start an order to find out the amount; You are required to put down a deposit; The pricing structure is much higher than other services at $100 for a 1,000-word essay. Shorter text is $60 for 250 words. #6. Studdit Studdit is a newest medical school personal statement editing and writing company for college and grad school students. They provide high-quality editing and proofreading services for students who need help with their essays, personal statements, applications, CVs, and cover letters. As part of the process, they'll ask you questions about yourself, your academic history, and why you want to study at a university in the USA or in the UK. Then they'll help you express yourself in the best possible way by editing and proofreading your statement until it sounds just right. After submitting your requirements, you’ll be assigned a professional writer who will work on your paper until it is ready to be submitted. Once the final payment has been received, you will receive a draft copy of your essay so that you may review it before making any changes if necessary. After receiving confirmation from you that the draft sent to you has been accepted, the final draft will be completed. The application process for college can be very stressful, which is they offer services at an affordable price. This company was founded by college students who wanted to help others through this process, and are passionate about helping you succeed! Advantages: Many options to choose from; Certified writers; 24/7 customer support; Email & text alerts; 3 free revisions included. Disadvantages: Pricing is higher than others at $13 per page, with higher pricing for certain types of high-level writing. #7. Expert-Editing Expert-Editing is a personal statement writing/editing provider that offers affordable, high-quality, and expertly written personal statements. They have helped thousands of students secure their dream university placement. Their professional writers have written over 10,000 personal statements for students from around the world. Many are highly qualified and experienced professionals with degrees in English Literature, Linguistics, or other related subjects. They will ensure that your essay is well written in accordance with Harvard, Yale, and Stanford standards. The company has worked with many schools over the past few years to understand what makes a good personal statement and has even created an entire section on their website to help people write their own personal statements. After the writer has finished the first draft, you will receive a copy of your essay to review. If there are any changes that need to be made, those changes will be made and you will receive another proofread version of the paper. Upon your approval of the final draft, we will send your electronic copy as well as a hard copy to the email provided. Advantages: Professional services; Intuitive website; Quick deadlines; Plagiarism and quality checks. Disadvantages: Pricing is the highest of the services mentioned at $13 per page, although that is for quick delivery. If you have a flexible timeline, two weeks is much less expensive. FAQ What is a personal statement? A personal statement is a short description of your background, interests, and goals. It is usually required as part of the application process for university, college, graduate school or postgraduate. The purpose of this essay is to give admissions officers an insight into who you are as a person and why you would make an excellent student at their school. This essay allows you to show off your personality through your writing style and provide concrete examples of how you will excel in your program. In addition to an academic transcript and test scores, your personal statement can make or break your chances of being accepted into a university or college program. While grades and test scores are important pieces of information that allow admissions officers to make informed decisions about whether or not they want to admit you, it's up to them whether or not they really want to spend time getting to know you better by reading your personal statement. By reading these essays, they get a glimpse into your personality and character as well as your interests outside of academics. These essays also allow them to identify students who have overcome significant challenges or obstacles during high school, which can be very impressive! What is a personal financial statement? A personal financial statement is a document that describes your financial situation. Your personal financial statement can be an important tool if you are applying for credit cards, loans, or insurance policies. You may need to provide a copy of your personal financial statement when applying for certain types of services or loans. Why is it required for colleges? A personal financial statement is used by government agencies and nonprofit organizations to determine eligibility for certain programs, including student loans and grants. By submitting a personal financial statement with your application, you can demonstrate your ability to pay tuition fees or other expenses associated with attending college. Some colleges also require applicants to supply parents' income information as part of their financial aid packages. In addition to being required by banks and other lenders, your personal financial statement can also be used by insurance companies and employers when deciding whether or not they want to hire someone or offer them employment benefits such as health care coverage and retirement plans. Depending on your income for the previous year, you may be eligible for additional grants that you might not otherwise know about. What is a personal mission statement? A personal mission statement is a short statement that describes who you are, what your values are, and what you want to accomplish in life. It’s a great tool for developing a sense of purpose and direction, especially during times of transition such as college applications. Your personal mission statement should be written in the first person and be concise. It’s also important to keep in mind that your personal mission statement should not be limited to academics or college admissions; it can be used throughout your life to guide decisions about jobs, relationships, and other major life events. A well-crafted personal mission statement can help you stand out from other applicants by giving the reader insight into who you are beyond grades, test scores, and activities. It allows them to see your passions, strengths, and weaknesses from your own point of view instead of an outside source like a teacher or counselor. The most effective statements are those that are honest, specific, and concrete so they can be read with ease by anyone who reads them (whether they be admissions officers or future employers). What is a law school personal statement? The personal statement as it applies to law school is your chance to let the admissions committee know who you are. You may write about any aspect of your background, including your professional experience, extracurricular activities, volunteer work, or any other information that you believe will help the committee decide whether or not they should admit you into their program. Many top-tier law schools receive thousands of applications each year, and cannot review every single one individually; instead, they rely on standardized tests like the LSAT and GPA as well as their application essays in order to determine which applicants are best suited for their programs. A strong application essay can be the deciding factor between admission and rejection because it gives an insight into who you are as a person rather than just an academic score or LSAT score alone could ever provide. What is a medical school personal statement? A medical school personal statement is an essay that describes your reasons for applying to medical school, your preparation for and commitment to this career path, your strengths as a future physician, and any other information that may be relevant to the admissions committee. Medical schools ask for this essay because they want to get to know the “real” you before making a decision about whether or not they want you in their program. In addition, because there are so many applicants for each spot at medical school (the average student applies to 8-10 programs), it helps them sort through all the applications quickly and easily. These essays are very helpful in assessing your personality and ability to communicate effectively. Since they only have one chance at getting into medical school (unlike undergraduates who can take multiple tests), it’s very important that students show themselves off in their best light with this essay. What is a personal vision statement? A personal vision statement is a 2-3 sentence statement that describes what you want to do with your life and how you're going to get there. It's a way to tell the admissions office what excites you and what you want to accomplish. Colleges are looking for students who have specific goals, who know what they want out of their education and beyond, and who have the drive and focus needed to achieve those goals. Your personal vision statement can help them identify those qualities in you. Your statement should be honest, but it doesn't need to be long or complicated. Think about what your top priorities are in life right now, and how college fits into those priorities. What do you want to pursue after graduation? What kind of impact do you hope to have on the world? How will attending this particular school help advance your goals? Your goal is not only to demonstrate your strengths as an applicant but also to show that you're someone who's thoughtful enough about his/her own life goals to articulate them clearly in writing). What is a residency personal statement? A residency personal statement is a written piece of writing that describes the reasons for pursuing residency. It is usually written by medical school applicants and can vary from one medical school to another. The residency personal statement is meant to show your enthusiasm for medicine and express why you are interested in becoming a doctor. Your residency personal statement should be honest about your motivations for applying for medical school, but it should also be specific enough to convey the unique aspects of your personality that will make you an excellent physician. Writing a residency personal statement can be difficult because there are so many ways to approach the task. The most effective way is to write down everything that comes to mind and then organize those ideas into a coherent narrative based on your own experience with medicine or healthcare. Is it legit to use a personal statement writing services? It is indeed a very common thing to do these days. A lot of students are opting for the help of professional writers to write their personal statements. The reason is obvious; they want a high-quality personal statement that can get them into their dream college. But there are a lot of people who think that this is plagiarism, which is against the rules. It is not however if you use the paper as research for writing the copy in your own words. Plagiarism is submitting someone else’s work as your own. These services do not intend for you to hand in these papers as your submission. They expect you to take inspiration from their writing and understand how it is to be formatted when writing your own. That is what makes them a legal business. The truth is that most college students have no idea how to write a personal statement, let alone the first thing about what to include in it. This is one of the reasons why many students struggle when it comes to writing their college essays. However, there are many personal statements writing services that you can use if you don't have any idea how to write your own personal statement. How to hire the best personal statement writer? When you are looking for a personal statement writer, you should look for someone who has a good understanding of the college application process. The personal statement is the most important part of your application, so it needs to be written by someone who can understand your situation and help you craft an effective essay. The first step in hiring a personal statement writer is to find out what kind of experience they have. You need to make sure that they have written college admissions essays before. If they haven't, then they probably won't be able to provide you with the help that you need, which means that it would be better to hire someone else instead. You should also look at their previous work when deciding whether or not someone is right for your needs. It's important that you ask for samples of their work before hiring them so that you can see what kind of quality they offer their customers. If their samples don't impress you, then it might be best if you continue looking elsewhere for help with your personal statement. Going with one of the top-rated writing services, like 99Papers, will ensure that you find a writer who meets your needs at the right price. They have done all the work for you. What is the best personal statement writing services in USA and UK? The most important thing in a personal statement is that it should be authentic and not exaggerated. You should be able to show your own personality in it without trying to sound like someone else. You must be able to convince the reader that your desire for higher education is genuine and sincere. The best personal statement writing/editing companies in USA and UK will give you an idea about how to write such kinds of essays effectively so that they impress the readers easily. They will help you write an inspiring statement that will convince them that you are really interested in pursuing higher studies at their institution of choice. When choosing the best personal writing services in the US or UK, you should opt for PaperHelp or EssayFactory. If you are a first-time student, they can help point you in the right direction and give you the help you need to get the placement you want. In the end... While some students may be deterred by the idea of paying for an online service to write their personal statement, it is essential to remember that this is one very important document that could make or break your application. The fact that you don't know how to begin properly shows fear, and fear never managed to get anyone into a great university. If you want nothing but the best for yourself and want a worry-free process, then hire a professional service to help you write your essays and personal statements. You’ll get 100% unique content written for you by industry experts that will inspire you to create a stunning application that is sure to get you into Harvard. Contact Details Writing Solutions Will Collins contact@legitwritingservice.com Company Website https://legitwritingservice.com

September 18, 2022 10:49 PM Eastern Daylight Time

The future of safe cancer care explored in PATIENT SAFETY

Patient Safety Authority

An estimated 1 in every 182 Americans will be diagnosed with cancer this year. Providing them safe care has become more complex as testing and treatment have become more sophisticated. What should patients know about the challenges inherent in quickly determining the correct diagnosis? How can they differentiate between disease symptoms and side effects from their treatment? These are just a few of the questions addressed in the September issue of PATIENT SAFETY. In recognition of World Cancer Research Day on September 24, PATIENT SAFETY spoke with medical oncologist Dr. Joe Jacobson, the former chief quality officer of the Dana-Farber Cancer Institute. He explains that when it comes to getting a timely and correct diagnosis, there may be dozens of steps required. Highly sophisticated genetic testing gives medical experts the ability to identify cancer subtypes, which he explains “may have profound consequences on prognosis and treatment options.” He notes that patients need an oncologist who understands how to distill so much information. Once treatment begins, the patient should share symptoms sooner rather than later via patient portals, if possible. “All cancer clinicians spend a substantial part of their day trying to distinguish between the symptoms of the disease and the symptoms due to complications of treatment. It requires a trained ear and a trained eye and vigilance. “Studies have shown that patients who report their symptoms electronically to centers that are equipped to manage them in real time fare better,” he adds. Other topics in this issue of PATIENT SAFETY include: The hidden risk of wheelchair use – One of the most common medical devices found in every healthcare facility, wheelchairs are underappreciated as a potential source of injury to patients. Research by Patient Safety Authority ’s Molly Quesenberry uncovers the risks of improper wheelchair use and offers strategies for healthcare facilities and staff. Medication safety Q&A – Is there a difference between generic and brand names? How often should you review your medication list with your provider? A medication safety fellow and emergency room nurse, Michelle Bell of the Patient Safety Authority, and medication safety officer Sharon Camperchioli of Children’s Hospital of Philadelphia answer patient medication questions. PATIENT SAFETY is the peer-reviewed journal of the Patient Safety Authority. A scientific publication, PATIENT SAFETY humanizes patient harm with stories, opinion pieces, and magazine-quality design. It has a readership of more than 45,000 people in 164 countries. About PSA Established under the Medical Care Availability and Reduction of Error (MCARE) Act of 2002, the PSA, an independent state agency, collects and analyzes patient safety data to improve safety outcomes and help prevent patient harm. http://patientsafety.pa.gov/ Contact Details Bev Volpe +1 609-230-4696 bev@madisongall.com Company Website http://patientsafety.pa.gov/

September 16, 2022 03:01 PM Eastern Daylight Time

Image

Two in Three Don't Have Access to Mental Health Care

The Chicago School of Professional Psychology

Consider what would happen if: Two in three patients with heart disease couldn't find a cardiologist? Two in three cancer patients couldn't find an oncologist? Two out of three children couldn't see a pediatrician? Researchers found that this is already the case today: two in three people who need mental health services do not receive them. “The lack of access is due to a growing need for services at a time when there are not enough resources for training and funding of more mental health professionals,” said Dr. Michele Nealon, President of The Chicago School of Professional Psychology, a non-profit multi-campus institution that has trained mental health professionals for more than 40 years. “There is a growing disparity between the haves and have nots, when it comes to mental health care access,” she said. “If you are a person of color or live in a rural area, you are far less likely to get the care you need.” A new report from the California Health Care Foundation shows that the Bay Area has 19 licensed psychiatrists and 73 licensed psychologists per 100,000 people –significantly more than the state averages of 12 and 44. At the other end of the spectrum, the San Joaquin Valley has six psychiatrists and 16 psychologists for the equivalent number of people. “This is a serious situation, since we know that more than one in five Americans (adults and children) have mental health or substance abuse conditions,” said Dr. Nealon. About The Chicago School of Professional Psychology Integrating theory with hands-on experience, The Chicago School of Professional Psychology provides education rooted in a commitment to innovation, service, and community for thousands of diverse students across the United States and globally. Founded in 1979, the nonprofit, regionally accredited university now features campuses in iconic locations across the country (Chicago, Southern California, Washington, D.C., New Orleans, Dallas) and online. TCSPP continues to expand its educational offerings beyond the field of psychology to offer more than 30 degrees and certificates in the professional fields of health services, education, counseling, business, and more. Through its engaged professional model of education, commitment to diversity and inclusion, and an extensive network of international partner institutions, The Chicago School’s students receive real-world training opportunities that reflect their future careers. The Chicago School is a proud affiliate of TCS, a nonprofit system of colleges advancing student success and community impact. To learn more, visit www.thechicagoschool.edu. Contact Details Vivien Hao +1 323-893-4743 vhao@thechicagoschool.edu

September 15, 2022 05:02 PM Eastern Daylight Time

Healthcare

Advanced AI Drug Development Platform 'DeepMatcher®' 2.0 Launches Worldwide (226330.KQ)

Aqua Cultured Foods Unveils Alt-Seafood Dumpling Fillings for Asian Food Go-to-Market Partners

Under The Hood Of Options Chain Implications — Understanding How Options Data Can Help Inform Investment Decisions

California Passes Landmark Clean Lighting Bill

Understanding Hearing Loss: Don’t Miss Out on Hearing the Moments that Matter Most

NanoViricides Reports Its Novel Monkeypox Antiviral Could Reach Clinical Status Rapidly

7 Best Personal Statement Writing Services for Colleges and Grad Schools

The future of safe cancer care explored in PATIENT SAFETY

Two in Three Don't Have Access to Mental Health Care